cholesta-5,8-dien-3 beta-ol has been researched along with lanosterol in 1 studies
| Studies (cholesta-5,8-dien-3 beta-ol) | Trials (cholesta-5,8-dien-3 beta-ol) | Recent Studies (post-2010) (cholesta-5,8-dien-3 beta-ol) | Studies (lanosterol) | Trials (lanosterol) | Recent Studies (post-2010) (lanosterol) |
|---|---|---|---|---|---|
| 36 | 1 | 8 | 1,010 | 8 | 335 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, R; de Barse, M; de Sain-van der Velden, MG; Prinsen, BH; Verrips, A; Visser, G | 1 |
1 other study(ies) available for cholesta-5,8-dien-3 beta-ol and lanosterol
| Article | Year |
|---|---|
Elevated cholesterol precursors other than cholestanol can also be a hallmark for CTX.
Topics: Biomarkers; Chenodeoxycholic Acid; Child; Child, Preschool; Cholestadienols; Cholestanol; Cholesterol; Dehydrocholesterols; Humans; Lanosterol; Male; Predictive Value of Tests; Sitosterols; Time Factors; Treatment Outcome; Up-Regulation; Xanthomatosis, Cerebrotendinous | 2008 |